Publication | Closed Access

Combination of doxorubicin and low-intensity ultrasound causes a synergistic enhancement in cell killing and an additive enhancement in apoptosis induction in human lymphoma U937 cells

Lymphoid NeoplasiaApoptosis InductionMedicinePathologyCell DeathImmunotherapyOncologyRadiation OncologyLow-intensity UltrasoundTumor MicroenvironmentAdditive Enhancement